首页> 外文期刊>Frontiers in Genetics >Analyzing Genome-Wide Association Study Dataset Highlights Immune Pathways in Lip Bone Mineral Density
【24h】

Analyzing Genome-Wide Association Study Dataset Highlights Immune Pathways in Lip Bone Mineral Density

机译:分析基因组 - 范围协会研究数据集突出了唇骨矿物密度的免疫途径

获取原文
           

摘要

Osteoporosis is a common complex human disease. Until now, large-scale genome-wide association studies (GWAS) using single genetic variant have reported some novel osteoporosis susceptibility variants. However, these risk variants only explain a small proportion of osteoporosis genetic risk, and most genetic risk is largely unknown. Interestingly, the pathway analysis method has been used in investigation of osteoporosis mechanisms and reported some novel pathways. Until now, it remains unclear whether there are other risk pathways involved in BMD. Here, we selected a lip BMD GWAS with 301,019 SNPs in 5,858 Europeans, and conducted a gene-based analysis (SET SCREEN TEST) and a pathway-based analysis (WebGestalt). On the gene level, BMD susceptibility genes reported by previous GWAS were identified to be the top 10 significant signals. On the pathway level, we identified 27 significant KEGG pathways. Three immune pathways including T cell receptor signaling pathway (hsa04660), complement and coagulation cascades (hsa04610), and intestinal immune network for IgA production (hsa04672) are ranked the top three significant signals. Evidence from the PubMed and Google Scholar databases further supports our findings. In summary, our findings provide complementary information to these nine risk pathways.
机译:骨质疏松症是一种常见的综合性疾病。到目前为止,使用单遗传变异的大规模基因组 - 范围协会研究(GWAs)报道了一些新的骨质疏松症易感变体。然而,这些风险变体仅解释了骨质疏松症遗传风险的少量比例,并且大多数遗传风险在很大程度上是未知的。有趣的是,途径分析方法已用于骨质疏松症机制的调查,并报告了一些新途径。到目前为止,仍然尚不清楚BMD是否有其他风险途径。在这里,我们选择了唇部BMD GWA,在5,858欧洲,并进行了基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于基于的分析(用于基于途径的分析(WebGestAlt)。在基因水平上,先前GWA报告的BMD易感基因被鉴定为前10个显着信号。在途径水平上,我们确定了27个重要的Kegg途径。包括T细胞受体信号传导途径(HSA04660),补体和凝固级联(HSA04610)的三种免疫途径,以及用于IgA生产的肠免疫网络(HSA04672)被评为前三个显着信号。来自PubMed和Google Scholar数据库的证据进一步支持我们的调查结果。总之,我们的调查结果为这九九风险途径提供了互补的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号